Reuters logo
7 months ago
BRIEF-Pieris Pharma, Servier announce broad collaboration in immuno-oncology
January 5, 2017 / 12:28 PM / 7 months ago

BRIEF-Pieris Pharma, Servier announce broad collaboration in immuno-oncology

1 Min Read

Jan 5 (Reuters) - Pieris Pharmaceuticals Inc :

* Pieris Pharmaceuticals Inc - co and Servier announced a broad collaboration in immuno-oncology

* Pieris Pharmaceuticals Inc - financial terms of collaboration include an upfront payment to Pieris of eur30 million

* Pieris Pharmaceuticals Inc - Pieris may also receive FTE funding for specific projects, an option fee upon potential expansion of collaboration

* Pieris Pharmaceuticals Inc - to get up to EUR324 million in success-based payments for PRS-332, up to EUR193 million in success-based payments for each of other programs Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below